QuickView for C-FMS;jsessionid=C3573561C82F2633AC01D5B18CDE5741;jsessionid=EEE5F445257F5218500D2433C50F11FC;jsessionid=57C7CED8C80CF0CE2E53C141A4AA1996;jsessionid=BA7615F9B21A7F2A54DD9B1088F268C3;jsessionid=C68E6BF8ABE52705CF7A84331640C1C4 (gene)

1. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
2. A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation.
3. Engineering an inhibitor-resistant human CSF1R variant for microglia replacement.
4. A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibito…
5. CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tau…

There were no clinical trials for C-FMS;jsessionid=C3573561C82F2633AC01D5B18CDE5741;jsessionid=EEE5F445257F5218500D2433C50F11FC;jsessionid=57C7CED8C80CF0CE2E53C141A4AA1996;jsessionid=BA7615F9B21A7F2A54DD9B1088F268C3;jsessionid=C68E6BF8ABE52705CF7A84331640C1C4